A Comprehensive Geriatric Assessment (CGA) is a set of tests used to evaluate a patient's medical, social, and functional status, and can identify impairments in these domains that may not be noticed otherwise. Prior studies have shown that a CGA can accurately predict which patients are more likely to have serious side effects from cancer treatment. However, it is unknown whether interventions can be done to address the impairments found during a CGA in order to reduce the risk of these side effects. This pilot study will test the feasibility of targeted interventions for deficits identified during a CGA in patients 65 years or older with bladder cancer that have not yet started treatment.
This study will enroll patients with muscle-invasive bladder cancer that have not yet started
systemic cancer treatment. The participants will complete a CGA and patient-reported outcome
(PRO) measures at baseline. Based on any impairments found during the CGA, participants will
be referred to specialists to help address these difficulties. Participants will complete the
CGA and PRO measures again at 3 months and 1 year after the initial assessment. The goal of
this study is to see if patients with advanced bladder cancer are interested in referrals to
specialists to address their impairments, and whether participants attend those appointments.
| Overal Status | Start Date | Phase | Study Type |
|---|---|---|---|
| Recruiting | January 21, 2020 | N/A | Interventional |
Primary Outcome 1 - Measure: Patient interest in impairment-directed interventions
Primary Outcome 1 - Time Frame: 1 year
Criteria:
Inclusion Criteria:
- Age 65 years or older
- Confirmed diagnosis of muscle-invasive bladder cancer
- Plan to undergo systemic treatment but have not yet started therapy
Exclusion Criteria:
- Must be able to read English
Show More
Gender: All
Minimum Age: 65 Years
Maximum Age: N/A
Healthy Volunteers: No
Name: Hyman Muss, MD
Role: Principal Investigator
Affiliation: University of North Carolina, Chapel Hill
Name: Chelsea Osterman, MD
Phone: 9849740000
Email: chelsea.osterman@unchealth.unc.edu
| Facility | Status | Contact |
|---|---|---|
| Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill Chapel Hill, North Carolina 27599 United States |
Recruiting |
Chelsea Osterman, MD 984-974-0000 chelsea.osterman@unchealth.unc.edu |
